Quantum Financial Advisors LLC Makes New $580,000 Investment in Kenvue Inc. $KVUE

Quantum Financial Advisors LLC acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 33,629 shares of the company’s stock, valued at approximately $580,000.

Several other institutional investors and hedge funds have also modified their holdings of KVUE. MAI Capital Management lifted its holdings in Kenvue by 4.3% in the second quarter. MAI Capital Management now owns 37,235 shares of the company’s stock valued at $779,000 after acquiring an additional 1,529 shares during the period. Journey Strategic Wealth LLC purchased a new position in shares of Kenvue during the 2nd quarter valued at approximately $310,000. Mufg Securities Americas Inc. increased its holdings in shares of Kenvue by 25.4% during the 2nd quarter. Mufg Securities Americas Inc. now owns 42,551 shares of the company’s stock valued at $891,000 after purchasing an additional 8,614 shares in the last quarter. AlphaCore Capital LLC lifted its stake in shares of Kenvue by 9.9% in the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after purchasing an additional 476 shares during the period. Finally, Rhumbline Advisers boosted its holdings in Kenvue by 0.4% during the second quarter. Rhumbline Advisers now owns 3,568,700 shares of the company’s stock worth $74,693,000 after buying an additional 15,534 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of a number of analyst reports. Canaccord Genuity Group upped their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Citigroup lifted their price target on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. UBS Group upped their price target on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and lowered their price target for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Finally, Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Three investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $19.58.

Kenvue Trading Up 1.2%

KVUE stock opened at $17.61 on Tuesday. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The business’s 50-day moving average is $17.98 and its 200 day moving average is $17.15. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The stock has a market cap of $33.75 billion, a price-to-earnings ratio of 22.87, a PEG ratio of 3.95 and a beta of 0.51.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.26 earnings per share. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were issued a $0.2075 dividend. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.